NDC product
ASTRAZENECA COVID-19 VACCINE
NDC 0310-1222 · AstraZeneca Pharmaceuticals LP
Key facts
| Product NDC | 0310-1222 |
|---|---|
| Proprietary name | ASTRAZENECA COVID-19 VACCINE |
| Labeler | AstraZeneca Pharmaceuticals LP |
| Marketing category | EMERGENCY USE AUTHORIZATION |
| Marketing start | Dec 22, 2020 |
| Marketing end | Dec 22, 2020 |
| Listing certified through | Dec 22, 2020 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: